# Stem Cell in Acute Myocardial Infarction

> **NCT04340609** · PHASE1,PHASE2 · COMPLETED · sponsor: **PT. Prodia Stem Cell Indonesia** · enrollment: 4 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT04340609
- **Lead sponsor:** PT. Prodia Stem Cell Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-11
- **Primary completion:** 2021-04-08
- **Final completion:** 2022-04-08
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2022-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04340609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04340609, "Stem Cell in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04340609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
